Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Report on carcinogens. Monograph on .. | book series | 2 | 2 | 5 | 589 | 0 | 5 | 0.00 | 294.50 | ||
2 | Drug Resistance Updates | journal | 4.319 Q1 | 132 | 18 | 70 | 3179 | 983 | 70 | 12.31 | 176.61 | |
3 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 8 | 682 | 1 | 8 | 0.20 | 170.50 | ||
4 | Seminars in Cancer Biology | journal | 3.259 Q1 | 179 | 117 | 212 | 16584 | 1948 | 193 | 7.75 | 141.74 | |
5 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 2.988 Q1 | 159 | 58 | 170 | 8081 | 1310 | 168 | 6.91 | 139.33 | |
6 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.276 Q4 | 50 | 30 | 26 | 4168 | 24 | 20 | 1.41 | 138.93 | |
7 | Annual Review of Cancer Biology | book series | 36 | 23 | 24 | 2932 | 118 | 23 | 4.92 | 127.48 | ||
8 | Frontiers in Nanobiomedical Research | book series | 0.119 Q4 | 2 | 18 | 48 | 2249 | 3 | 13 | 0.06 | 124.94 | |
9 | Advances in Cancer Research | journal | 109 | 35 | 107 | 4335 | 605 | 0 | 4.57 | 123.86 | ||
10 | Sub-Cellular Biochemistry | journal | 1.298 Q2 | 81 | 73 | 226 | 8984 | 581 | 213 | 3.78 | 123.07 | |
11 | Cancer and Metastasis Reviews | journal | 2.427 Q1 | 167 | 62 | 157 | 7429 | 954 | 153 | 6.17 | 119.82 | |
12 | Critical Reviews in Oncogenesis | journal | 0.631 Q3 | 57 | 26 | 113 | 2907 | 172 | 101 | 0.83 | 111.81 | |
13 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.529 Q3 | 52 | 33 | 88 | 3586 | 192 | 82 | 2.10 | 108.67 | |
14 | Cancer Drug Resistance | journal | 24 | 18 | 0 | 1724 | 0 | 0 | 0.00 | 95.78 | ||
15 | Current Cancer Drug Targets | journal | 0.875 Q3 | 103 | 87 | 227 | 8117 | 521 | 202 | 2.15 | 93.30 | |
16 | Signal Transduction and Targeted Therapy | journal | 117 | 31 | 58 | 2821 | 350 | 54 | 6.03 | 91.00 | ||
17 | Progress in Tumor Research | book series | 0.858 Q3 | 12 | 10 | 23 | 907 | 46 | 22 | 2.17 | 90.70 | |
18 | Journal of Mammary Gland Biology and Neoplasia | journal | 1.196 Q2 | 112 | 22 | 54 | 1932 | 175 | 51 | 2.86 | 87.82 | |
19 | Cancers | journal | 2.142 Q1 | 133 | 521 | 417 | 45507 | 2554 | 407 | 6.51 | 87.35 | |
20 | Mini-Reviews in Medicinal Chemistry | journal | 0.609 | 107 | 124 | 419 | 9892 | 1022 | 373 | 2.49 | 79.77 | |
21 | Advances in Biological Regulation | journal | 1.882 Q1 | 69 | 54 | 107 | 4263 | 774 | 100 | 6.45 | 78.94 | |
22 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 9 | 156 | 0 | 9 | 0.00 | 78.00 | ||
23 | Endocrine-Related Cancer | journal | 1.985 Q1 | 146 | 157 | 400 | 11276 | 1991 | 366 | 4.54 | 71.82 | |
24 | Seminars in Radiation Oncology | journal | 1.465 Q2 | 103 | 41 | 130 | 2941 | 482 | 118 | 2.93 | 71.73 | |
25 | Molecular Cancer | journal | 3.274 Q1 | 196 | 164 | 449 | 11755 | 4299 | 434 | 10.87 | 71.68 | |
26 | Current Hematologic Malignancy Reports | journal | 1.149 Q2 | 44 | 61 | 186 | 4328 | 538 | 184 | 2.77 | 70.95 | |
27 | Current Pathobiology Reports | journal | 33 | 31 | 90 | 2193 | 164 | 90 | 1.88 | 70.74 | ||
28 | Frontiers in Oncology | journal | 1.918 Q1 | 136 | 637 | 903 | 44276 | 4157 | 828 | 4.19 | 69.51 | |
29 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 18 | 43 | 1247 | 214 | 43 | 4.07 | 69.28 | ||
30 | Cancer Treatment and Research | journal | 0.641 Q3 | 65 | 40 | 132 | 2769 | 332 | 74 | 1.90 | 69.23 | |
31 | Stem Cell Reviews and Reports | journal | 1.436 Q2 | 87 | 79 | 223 | 5291 | 1043 | 212 | 4.61 | 66.97 | |
32 | Oncology Reviews | journal | 1.257 Q2 | 31 | 18 | 25 | 1194 | 120 | 25 | 5.44 | 66.33 | |
33 | Nature Reviews Cancer | journal | 28.061 Q1 | 505 | 117 | 352 | 7724 | 8706 | 190 | 25.41 | 66.02 | |
34 | Journal of Hematology and Oncology | journal | 2.960 Q1 | 144 | 135 | 425 | 8852 | 3345 | 417 | 8.51 | 65.57 | |
35 | npj Precision Oncology | journal | 36 | 27 | 1 | 1764 | 4 | 1 | 4.00 | 65.33 | ||
36 | Cancer Letters | journal | 2.240 Q1 | 216 | 507 | 1476 | 33075 | 9670 | 1454 | 6.33 | 65.24 | |
37 | Genes and Cancer | journal | 1.041 Q2 | 81 | 19 | 109 | 1217 | 286 | 106 | 2.46 | 64.05 | |
38 | Cancer journal (Sudbury, Mass.) | journal | 1.499 Q2 | 102 | 51 | 208 | 3256 | 617 | 186 | 2.35 | 63.84 | |
39 | PLoS Genetics | journal | 4.001 Q1 | 271 | 577 | 2047 | 36817 | 10509 | 2025 | 4.70 | 63.81 | |
40 | Differentiation | journal | 1.246 Q2 | 107 | 40 | 115 | 2537 | 334 | 112 | 3.11 | 63.43 | |
41 | Clinical and Experimental Metastasis | journal | 1.229 Q2 | 109 | 71 | 186 | 4430 | 598 | 179 | 2.49 | 62.39 | |
42 | Nitric Oxide - Biology and Chemistry | journal | 1.015 Q2 | 110 | 132 | 272 | 8113 | 998 | 262 | 3.42 | 61.46 | |
43 | Angiogenesis | journal | 1.193 Q2 | 101 | 53 | 126 | 3250 | 691 | 124 | 5.77 | 61.32 | |
44 | Trends in Cancer | journal | 3.548 Q1 | 90 | 98 | 215 | 5909 | 1389 | 195 | 6.31 | 60.30 | |
45 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.528 Q3 | 108 | 218 | 518 | 13123 | 1043 | 487 | 1.91 | 60.20 | |
46 | Targeted Oncology | journal | 1.322 Q2 | 59 | 73 | 205 | 4317 | 728 | 200 | 3.74 | 59.14 | |
47 | Recent Results in Cancer Research | book series | 0.481 Q4 | 63 | 48 | 114 | 2818 | 308 | 48 | 2.70 | 58.71 | |
48 | Cellular oncology (Dordrecht) | journal | 1.457 Q2 | 58 | 54 | 144 | 3168 | 646 | 142 | 5.17 | 58.67 | |
49 | Current Cancer Therapy Reviews | journal | 0.140 Q4 | 17 | 15 | 63 | 860 | 12 | 52 | 0.22 | 57.33 | |
50 | Epigenomics | journal | 1.798 Q1 | 77 | 115 | 366 | 6453 | 1633 | 335 | 3.93 | 56.11 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®